Journals / art / 2020 / Cilt: 35 - Sayı: 1

Mononeuritis Multiplex Associated With Antiphospholipid Antibodies

Journal
art
Pages
146–148
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

He was treated with oral anticoagulant and mycophenolate mofetil, and is progressing favorably.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this article, we report the case of a 43-year-old male patient with mononeuritis multiplex associated with antiphospholipid antibodies.
📊
Key Findings & Data:The patient had no other clinical or laboratory features of other systemic or autoimmune diseases or systemic vasculitis.
💡
Conclusion & Impact:He was treated with oral anticoagulant and mycophenolate mofetil, and is progressing favorably.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

In this article, we report the case of a 43-year-old male patient with mononeuritis multiplex associated with antiphospholipid antibodies. The patient had no other clinical or laboratory features of other systemic or autoimmune diseases or systemic vasculitis. He was treated with oral anticoagulant and mycophenolate mofetil, and is progressing favorably.

🔖

Cite This Article

CORONA, L. F. V. S., N, A. D. A. B. (2020). Mononeuritis Multiplex Associated With Antiphospholipid Antibodies. art, Cilt: 35 - Sayı: 1, 146–148. https://ajindex.com/articles/206041

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Giannakopoulos B, Krilis SA. The pathogenesis of the antiphospholipid syndrome. N Engl J Med 2013;368:1033-44
  2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306
  3. Kafka SP, Condemi JJ, Marsh DO, Leddy JP. Mononeuritis multiplex and vasculitis. Association with anti-neutrophil cytoplasmic autoantibody. Arch Neurol 1994;51:565-8
  4. Sciascia S, Amigo MC, Roccatello D, Khamashta M. Diagnosing antiphospholipid syndrome: ‘extracriteria’ manifestations and technical advances. Nat Rev Rheumatol 2017;13:548-560
  5. Ricarte IF, Dutra LA, Abrantes FF, Toso FF, Barsottini OGP, Silva GS, et al. Neurologic manifestations of antiphospholipid syndrome. Lupus 2018;27:1404-14
  6. Jeruc J, Popovic M, Vizjak A, Jurcic V, Lestan B, Ferluga D. Multiple mononeuropathy due to vasculitis associated with anticardiolipin antibodies: a case report. Folia Neuropathol 2006;44:140-3
  7. Rodrigues CE, Carvalho JF. Multiple mononeuropathy secondary to thrombosis of the vasa nervorum in primary antiphospholipid syndrome. Isr Med Assoc J 2010;12:448-9
  8. Erten N, Saka B, Karan MA, Parman Y, Umman B, Tascioglu C. Catastrophic secondary antiphospholipid syndrome with peripheral nervous system involvement: a case report. Acta Med Okayama 2004;58:107-10
  9. Samson M, Puéchal X, Devilliers H, Ribi C, Cohen P, Bienvenu B, et al. Mononeuritis multiplex predicts the need for immunosuppressive or immunomodulatory drugs for EGPA, PAN and MPA patients without poor-prognosis factors. Autoimmun Rev 2014;13:945-53
  10. Zigon P, Podovsovnik A, Ambrozic A, Tomsic M, Hocevar A, Gaspersic N, et al. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements. Clin Rheumatol 2019;38:371-8
  11. Núñez-Álvarez CA, Hernández-Molina G, Bermúdez- Bermejo P, Zamora-Legoff V, Hernández-Ramírez DF, Olivares-Martínez E, et al. Prevalence and associations of anti-phosphatidylserine/prothrombin antibodies with clinical phenotypes in patients with primary antiphospholipid syndrome: aPS/PT antibodies in primary antiphospholipid syndrome. Thromb Res 2019;174:141-7
  12. Keswani SC, Chauhan N. Antiphospholipid syndrome. J R Soc Med 2002;95:336-42.